Universidad Complutense de Madrid
E-Prints Complutense

Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer

Impacto

Downloads

Downloads per month over past year

Castillo Romero, Rafael and Colilla, Montserrat and Vallet Regí, María (2016) Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer. Expert Opinion on Drug Delivery, 14 . pp. 229-243. ISSN 1742-5247

[img]
Preview
PDF
983kB

Official URL: http://www.tandfonline.com/loi/iedd20



Abstract

Introduction: Nanocarriers have emerged as a powerful alternative for cancer therapy.Indeed, they are promising candidates to tackle the acquired resistance of surviving cells against antiproliferative drugs – the so-called multidrug resistance (MDR) phenomenon – which has arisen as one of the major clinical issues of chemotherapy. Among nanocarriers, this review focuses on the recent approaches based on tailored mesoporous silica nanoparticles (MSNs) that could overcome this problem. Areas covered: Herein we summarize the current efforts developed to provide MSNbased nanosystems of enhanced dual therapeutic action against diseased cells. This can be accomplished by three main approaches: i) increasing nanosystems’ killing capability towards particular cells by enhancing both recognition and specificity; ii)increasing the apoptotic effect throughout co-delivery of several drugs; or iii)combining drug delivery with apoptosis induced by physical methods.
Expert Opinion: The development of multifunctional nanosystems able to exert the optimal therapeutic action through the minimal administration constitutes a major challenge in nanomedicine. Recent developments in advanced MSN-based platforms for drug delivery represent promising avenues in the management of MDR associated with cancer therapy. All strategies discussed in this manuscript demonstrate improvements against difficult-to-treat tumors.


Item Type:Article
Additional Information:

RESEARCHER ID M-3378-2014 (María Vallet Regí)
ORCID 0000-0002-6104-4889 (María Vallet Regí)

Uncontrolled Keywords:Cancer treatment; multidrug resistance; co-delivery; combination therapy; dual targeting; mesoporous silica nanoparticles
Subjects:Sciences > Chemistry > Chemical engineering
Sciences > Chemistry > Materials
Sciences > Chemistry > Chemistry, Inorganic
ID Code:40742
Deposited On:23 Jan 2017 12:58
Last Modified:01 Mar 2018 00:01

Origin of downloads

Repository Staff Only: item control page